valu usd unless otherwis note
bear case go hibern
view face grow neg sentiment around us
cigarett categori altria manag provid rare project
categori volum declin substanti better
estim grow number bear price also remain
healthi new promot effici measur continu help
greater clariti around juul crono deal also help dcf
suggest upsid current level reiter outperform
volum equat wors expect price stand altria
manag clear tradit secular declin rate
cigarett histor all-in expect medium
term due part e-vapor growth includ juul addit
headwind volum also due price elast manag
see unchang look forward expect price
remain pm usa price realiz past two year
see upsid estim addit state excis tax
pass seen past two year level price offset
declin expect altria smokeabl volum look forward
addit perspect juul manag provid help
addit insight juul busi consist
origin view tie-up provid addit clariti
valuat paid though suspect deal
compani current disclos quick point juul volum
trend current sale
juul us e-vapor market follow
juul revenu expect intern margin
consist us intern cigarett busi expect
juul also make progress regulatori front help understand
juul earn impact laid three assumpt set see page
base case scenario reflect model assum juul top-lin
grow compound-annual-growth-rate margin reach compound-annual-growth-rate
margin assumpt set would result addit
earn power
focus cash dcf valuat current level think mo share
compel price-to-earnings ev/ebitda especi
dividend yield spread bp vs versu average
revis estim new ep estim sit low end
manag initi guid believ total cigarett
volum year vs guidanc
off-set price point model littl equiti
incom contribut juul crono price target remain
impli upsid current level
price prior trade day market close estimate unless otherwis note
bloomberg capit market estim upside/downside/target
dcf-driven base case altria impli
price-to-earnings assum wacc lt top-lin compound-annual-growth-rate
termin growth rate estim call
cigarett volum declin price
dcf-driven upsid case altria assum
wacc lt top-lin compound-annual-growth-rate termin growth
rate scenario assum cigarett volum
declin low-end rang price
downsid scenario also base dcf
assum revenu compound-annual-growth-rate termin
growth rate primari driver scenario
acceler declin volum fall outsid
assumpt inabl off-set acceler
volum declin price materi slowdown
rate altria share outperform current price mo
share trade price-to-earnings yield
understand make valuat call consum stapl
realli work past year believ
current state overal cpg space make mo attract
place put new money within space compani
essenti hedg three biggest issu face
evolut sell tobacco product ban on-line
rise cost goods/logist make small
percentag cog
rise interest rate fulli acknowledg highlight
risk rate set rise project treasuri
rate rise year-end altria maintain
current yield dividend yield spread versu
would bp year-end
compel level bp benchmark take
account dividend increas altria made
consecut year
competitor product launch success price profil
competitor new product launch import watch
altria result
iqo fda approv roll-out altria manag note
fulli prepar roll iqo market upon
fda approv believ fda approv like howev
expect iqo materi contributor altria top-
line profit howev headlin disappoint around
iqo could spook investor saw upon philip
morri result includ sequenti
deceler iqo drive mo share lower
risk thesi
signific deceler industri volum declin
long-term averag noteworthi innov
e-cigarette/vapor front rise interest rate
deterior tobacco fundament
exhibit juul assumpt set earn impact
dcf-driven base case altria impli price-to-earnings assum wacc
lt top-lin compound-annual-growth-rate termin growth rate estim call
cigarett volum declin price price target support
outperform rate
risk rate price target
rise interest rate given tobacco stock often view bond proxi investor
fulli acknowledg highlight risk interest rate expect rise
project treasuri rate rise year-end altria
maintain current yield dividend yield spread versu would
bp year-end compel level bp benchmark take
account dividend increas altria made consecut
deterior tobacco fundament look forward see volum trend normal
back level like closer posit altria suspect abl
realiz consist price past quarter us cigarett industri volum
declin acceler believ follow factor contribut weak
excis tax increas import cigarett consumpt state ca/pa rise ga price
peak condit job lever tobacco consum construct hospit etc
gener lack wage inflat headwind continu would
risk fundament thesi
iqo fda approv roll-out altria manag note fulli prepar roll
iqo market upon fda approv believ fda approv like howev
expect iqo materi contributor altria top-lin profit howev
headlin disappoint around iqo could spook investor saw upon philip
morri result includ sequenti deceler iqo drive
altria group inc engag manufactur sale cigarett smokeless product
wine unit state offer cigarett primarili marlboro brand
smokeless tobacco product copenhagen skoal red seal huski marlboro
snu brand name cigar princip black mild brand pipe tobacco
compani also produc sell blend tabl wine chateau michel
columbia crest name distribut antinori villa maria estat wine champagn
nicola feuillatt unit state addit maintain portfolio leverag
direct financ leas aircraft rail surfac transport electr power real estat
manufactur compani found headquart richmond
ms except ep ratio
sale
net incom common non-gaap
compani report capit market estim
